Impact of COVID-19 Vaccination in Thailand: Averted Deaths and Severe Infections Across Age Groups
dc.contributor.author | Wilasang C. | |
dc.contributor.author | Suttirat P. | |
dc.contributor.author | Wannigama D.L. | |
dc.contributor.author | Amarasiri M. | |
dc.contributor.author | Chadsuthi S. | |
dc.contributor.author | Modchang C. | |
dc.contributor.correspondence | Wilasang C. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2025-01-05T18:10:29Z | |
dc.date.available | 2025-01-05T18:10:29Z | |
dc.date.issued | 2024-12-01 | |
dc.description.abstract | The COVID-19 pandemic has underscored the pivotal role of vaccines in mitigating the devastating impact of the virus. In Thailand, the vaccination campaign against SARS-CoV-2 began on 28 February 2021, initially prioritizing healthcare professionals before expanding into a nationwide effort on 7 June 2021. This study employs a mathematical model of COVID-19 transmission with vaccination to analyze the impact of Thailand’s COVID-19 vaccination program from 1 March 2021 to 31 December 2022. We specifically assess the potential loss of lives and occurrence of severe infections across various age groups in a hypothetical scenario where vaccines were not administered. By fitting our model with officially reported COVID-19 death data, our analysis reveals that vaccination efforts prevented a total of 300,234 deaths (95% confidence interval: 295,938–304,349) and averted 1.60 million severe COVID-19 infections (95% confidence interval: 1.54–1.65 million). Notably, the elderly population over 80 years old benefited the most from vaccination, with an estimated 84,518 lives saved, constituting 4.28% of this age group. Furthermore, individuals aged between 70 and 74 years experienced the highest reduction in severe infections, with vaccination potentially preventing 8.35% of this age bracket from developing severe COVID-19. | |
dc.identifier.citation | Tropical Medicine and Infectious Disease Vol.9 No.12 (2024) | |
dc.identifier.doi | 10.3390/tropicalmed9120286 | |
dc.identifier.eissn | 24146366 | |
dc.identifier.scopus | 2-s2.0-85213512818 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/102622 | |
dc.rights.holder | SCOPUS | |
dc.subject | Medicine | |
dc.subject | Medicine | |
dc.subject | Immunology and Microbiology | |
dc.title | Impact of COVID-19 Vaccination in Thailand: Averted Deaths and Severe Infections Across Age Groups | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85213512818&origin=inward | |
oaire.citation.issue | 12 | |
oaire.citation.title | Tropical Medicine and Infectious Disease | |
oaire.citation.volume | 9 | |
oairecerif.author.affiliation | Yamagata Prefectural Central Hospital | |
oairecerif.author.affiliation | Faculty of Science, Mahidol University | |
oairecerif.author.affiliation | UWA Medical School | |
oairecerif.author.affiliation | Naresuan University | |
oairecerif.author.affiliation | Tohoku University | |
oairecerif.author.affiliation | Faculty of Medicine, Chulalongkorn University | |
oairecerif.author.affiliation | Ministry of Higher Education, Science, Research and Innovation | |
oairecerif.author.affiliation | The University of Sheffield |